Ambev S.A. (NYSE:ABEV – Get Free Report) Director Ricardo Manuel Frangat Moreira sold 468,040 shares of the business’s stock in a transaction dated Thursday, July 30th. The stock was sold at an average price of $3.08, for a total transaction of $1,441,563.20. Following the transaction, the director owned 3,000,000 shares in the company, valued at $9,240,000. The trade was a 13.50% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
Ambev Stock Down 0.8%
ABEV stock opened at $3.10 on Friday. The company has a market cap of $48.78 billion, a price-to-earnings ratio of 15.47, a PEG ratio of 1.82 and a beta of 0.64. The company has a current ratio of 1.03, a quick ratio of 0.78 and a debt-to-equity ratio of 0.02. Ambev S.A. has a 12 month low of $2.10 and a 12 month high of $3.45. The firm has a 50-day moving average of $3.13 and a two-hundred day moving average of $3.03.
Ambev (NYSE:ABEV – Get Free Report) last issued its earnings results on Thursday, July 30th. The company reported $0.04 earnings per share for the quarter, hitting the consensus estimate of $0.04. The business had revenue of $3.89 billion for the quarter, compared to analysts’ expectations of $4.05 billion. Ambev had a return on equity of 17.71% and a net margin of 18.47%. As a group, analysts forecast that Ambev S.A. will post 0.2 earnings per share for the current fiscal year.
Ambev Dividend Announcement
Analysts Set New Price Targets
ABEV has been the topic of several recent research reports. Barclays boosted their price target on shares of Ambev from $3.00 to $3.50 and gave the company an “equal weight” rating in a research report on Wednesday, May 6th. Weiss Ratings downgraded shares of Ambev from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, May 6th. Wall Street Zen upgraded shares of Ambev from a “hold” rating to a “buy” rating in a report on Saturday. UBS Group increased their price target on shares of Ambev from $2.65 to $2.90 and gave the company a “sell” rating in a research note on Thursday, May 14th. Finally, Scotiabank downgraded shares of Ambev from a “sector outperform” rating to a “sector perform” rating in a report on Wednesday, July 15th. Five equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus target price of $3.09.
Check Out Our Latest Stock Analysis on ABEV
Institutional Trading of Ambev
Hedge funds and other institutional investors have recently modified their holdings of the business. Monument Capital Management purchased a new stake in Ambev in the 4th quarter valued at about $25,000. First Trust Advisors LP purchased a new position in Ambev during the third quarter worth about $25,000. Integrated Wealth Concepts LLC acquired a new stake in shares of Ambev during the first quarter valued at about $26,000. IHT Wealth Management LLC acquired a new stake in shares of Ambev during the fourth quarter valued at about $27,000. Finally, S Harris Financial Group LLC acquired a new stake in shares of Ambev during the fourth quarter valued at about $28,000. 8.13% of the stock is owned by institutional investors and hedge funds.
More Ambev News
Here are the key news stories impacting Ambev this week:
- Positive Sentiment: Ambev’s board approved approximately R$2.7 billion in interest-on-capital payments for 2026, including the third and final installment. The payout supports the stock’s income appeal and signals continued cash-return capacity. Ambev Approves R$2.7 Billion in Interest on Capital Payments for 2026
- Positive Sentiment: The brewer is preparing for hotter conditions associated with El Niño. Warmer weather could support demand for beer and other beverages, although the eventual effect will depend on regional weather patterns and operating costs. Ambev se prepara para clima mais quente com El Niño
- Neutral Sentiment: Barclays reaffirmed its Hold rating, indicating the analyst does not see a sufficiently compelling near-term catalyst to change its stance. Barclays Reaffirms Their Hold Rating on Ambev SA
- Neutral Sentiment: Ambev filed its July Form 6-K, reaffirming its U.S. reporting status. The filing is a routine compliance update with limited direct effect on valuation. Ambev July 2026 Form 6-K
- Negative Sentiment: Ambev’s latest results were mixed: adjusted EPS of $0.04 met consensus, but revenue of $3.89 billion fell short of the $4.05 billion estimate. The top-line miss is the clearest reason for investor pressure, suggesting weaker-than-expected sales momentum despite earnings execution. Ambev Q2 2026 Earnings Call Transcript
Ambev Company Profile
Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.
The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.
Featured Articles
- Five stocks we like better than Ambev
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Ambev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev and related companies with MarketBeat.com's FREE daily email newsletter.
